Publications

Search our bibliography using the filters on the right-hand side.

Displaying 401 through 450 of 725 publications.

Bartis D, Crowley LE, D'Souza VK, Borthwick L, Fisher AJ, Croft AP, Pongracz JE, Thompson R, Langman G, Buckley CD, Thickett DR. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis. BMC Pulm Med. 2016 Apr 14;16(1):51. doi: 10.1186/s12890-016-0211-7

Yu S, Schwab P, Bian B, Radican L, Tunceli K. Use of add-on treatment to Metformin monotherapy for patients with type 2 Diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016 Mar;22(3):272-80. doi: 10.18553/jmcp.2016.22.3.272

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Res Care. 2016 Feb 18;4(1):e000099. doi: 10.1136/bmjdrc-2015-000099

Musich S, MacLeod S, Bhattarai GR, Wang SS, Hawkins K, Bottone, Jr. FG, Yeh CS. The impact of obesity on health utilization and expenditures in a medicare supplement. Gerontol Geriatr Med. 2016 Jan 19;2:233372141. doi: 10.1177/2333721415622004

Strober B, Sigurgeirsson B, Popp G, Sinclair R, Krell J, Stonkus S, Septe M, Elewski BE, Gottlieb AB, Zhao Y, Herrera V, Mordin M, Odom D, Papavassilis C, Nyirady J, Lebwohl M. Secukinumab provides clearer skin and better control on patient-reported psoriasis symptoms of itching, pain, and scaling than placebo and etanercept. J Psoriasis and Psoriatic Arthritis. 2016;1(4):167-75.

White MV, Silvia S, Hollis K, Wooddell M, Goss D, Odom D, Cooney D, Bartsch J, Hogue S. EPIPEN4SCHOOLS® survey combined analysis: prevalence and triggers of anaphylactic events. Poster presented at the 2016 AAAAI Annual Meeting; March 4, 2016. Los Angeles, CA. [abstract] J Allergy Clin Immunol. 2016; 137:AB52.

Darden CM, Price MA, Kaye JA, Sherif BN, Marion S, Tzivelekis S, Garcia J, Chandler D. Same-day administration of pegfilgrastim following myelosuppressive chemotherapy: practices and rationale. Blood. 2015 Dec 3;126(23):5585. doi: 10.1182/blood.V126.23.5585.5585

Fernandez MM, Wang J, Ye X, Kwong WJ, Sherif B, Hogue S, Sherrill B. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score slanted greater than or equal to 2. SAGE Open Med. 2015 Dec. doi: 10.1177/2050312115613350

Schwab PE, MacLean E, Chioda M, Moll K, Pasquale M, Mardekian J, Futch T. NSCLC observations combining medical charts and administrative claims data. Poster presented at the 2015 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5, 2015. Boston, MA. [abstract] Mol Tar Can Ther. 2015 Dec 1; 14(12 S2).

Balp MM, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Maurer M, Koenders J, Knulst AC, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Tian H, Elberink JN. Work productivity and activity impairment among chronic spontaneous/idiopathic urticaria patients: results from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Tian H, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Koenders J, Knulst AC, Elberink JN, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Balp MM, Maurer M. Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients- findings from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Silvia S, Hollis K, Wooddell MJ, Hogue S, White MV. The Epipen4schools® survey: prevalence and triggers of anaphylactic events in large US school districts. Presented at the 2015 ACAAI Conference; November 2015. San Antonio, TX.

Khan S, Zimovetz E, Healey P, Copley-Merriman K. Biologics in ulcerative colitis (UC): treatment guidelines, health technology assessments (HTA). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy. [abstract] Value Health. 2015 Nov; 18(7):A633.

Edson-Heredia E, Barrows S, Masaquel C, Nikai E, Mallbris L, Puig L. The value of achieving complete or near complete resolution of psoriasis. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Copley-Merriman K. Value for money: health economics. Presented at the University of Michigan; October 29, 2015. Ann Arbor, MI.

White MV, Silvia S, Hollis KA, Wooddell M, Hogue SL. Characteristics and treatment of anaphylactic events in a US school setting: results from the EPIPEN4SCHOOLS® program survey. Poster presented at the American Academy of Pediatrics 2015; October 24, 2015. Washington, DC. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 CSACI Annual Scientific Meeting; October 24, 2015. Vancouver, Canada. Previously presented at the 2015 Eastern Allergy Conference.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® program pilot survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 XXIV World Allergy Congress (WAC); October 16, 2015. Seoul, Korea.

D'Souza VK, Bartis D, Scott A, Smith FG, Thickett D. HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells. Poster presented at the ERS 2015 International Congress; September 2015. Amsterdam, The Netherlands. [abstract] Eur Respir J. 2015 Oct; 46(Suppl 59):939. doi: 10.1183/13993003.congress-2015.PA939

Raspa M, Sacco PN, Edwards AM, Bishop E, Wylie AC, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 2nd International Conference on FMR1 Premutation: Basic Mechanisms and Clinical Involvement; October 2015. Barcelona, Spain. Previously presented at the 48th Annual Gatlinburg Conference.

Strober B, Mordin M, Mollon, P, Williams N, Fox T, Papavassilis C, Lebwohl M. Secukinumab demonstrates greater impact on patient global impression of change than etanercept in moderate to severe psoriasis. Poster presented at the 24th European Academy of Dermatology and Venereology Congress; October 2015. Copenhagen, Denmark.

Weller K, Grattan C, Abuzakouk M, Berard F, Sussman G, Lynde C, Canonica GW, Knulst A, Ortiz De Frutos J, Nakonechna A, Gimenez-Arnau A, Oude Elberink JNG, Balp MM, Khalil S, Tian H, Hollis K, Sweeney C, Radder C, McBride D, Maurer M. Patient profile from the first international burden of illness study in inadequately controlled chronic spontaneous urticaria: ASSURE-CSU. Poster presented at the 24th European Academy of Dermatology and Venereology (EADV) Congress; October 2015. Copenhagen, Denmark.

Sheer R, Schwab PE, Noyes Essex M, Cappelleri JC, Reiners A, Bobula J, Pasquale M. Management due to sprains, strains and contusions in the Medicare population. Poster presented at the 2015 PAIN Week; September 8, 2015. Las Vegas, NV.

Sheer R, Schwab P, Essex MN, Cappelleri J, Reiners A, Bobula J, Pasquale M. Acute pain management due to sprains, strains and contusions in the medicare population. Poster presented at the PAINWeek 2015; 2015. Las Vegas, NV. [abstract] Postgrad Med. 2015 Sep 4; 127(S1):S86. doi: https://doi.org/10.1080/00325481.2015.1086533

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Differences in anaphylaxis-related risks by school grade level: findings from the EpiPen4Schools® survey. Poster presented at the 2015 ASCIA Conference; September 2015. Adelaide, Australia. [abstract] Intern Med J. 2015 Sep 3; 45(Suppl 4):3. doi: 10.1111/imj.12869

Vekeman F, Gauthier-Loiselle M, Faust E, Lefebvre P, Lahoz R, Duh MS, Sacco P. Patient and caregiver burden associated with fragile x syndrome in the United States. Am J Intellect Dev Disabil. 2015 Sep;120(5):444-59. doi: 10.1352/1944-7558-120.5.444

Sussman G, Lynde C, Zanganeh S, Lacuesta G, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Sweeney CT, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: an analysis of the diagnosis and treatment of patients with antihistamine-refractory CSU. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada. [abstract] Clin Transl Allergy. 2015 Aug 17; 5(29):1-7. doi: 10.1186/s13601-015-0072-9

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz De Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 17;17(5):29.

White MV, Goss D, Silvia S, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Goss D, Wooddell M, Hogue S, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools® survey. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Dancer RC, Parekh D, Lax S, D'Souza V, Zheng S, Bassford CR, Park D, Bartis DG, Mahida R, Turner AM, Sapey E, Wei W, Naidu B, Stewart PM, Fraser WD, Christopher KB, Cooper MS, Gao F, Sansom DM, Martineau AR, Perkins GD, Thickett DR. Vitamin D deficiency contributes directly to the Acute Respiratory Distress Syndrome (ARDS). Thorax. 2015 Jul;70(7):617-24. doi: 10.1136/thoraxjnl-2014-206680

Sussman G, Lynde C, Kanani A, Hebert J, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: redefining our understanding of the clinical characteristics of patients with CSU/CIU refractory to H1- antihistamines. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Grattan C, Lynde C, Abuzakouk M, Nakonechna A, Chiva-Razavi S, Halliday A, Chambenoit O, Hollis KA, McBride DW, Radder CN, Tian H, Balp MM. ASSURE-CSU preliminary UK and Canadian results: a characterisation of angioedema in patients with refractory CIU/CSU from the UK and Canada. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Nakonechna A, Lynde C, Grattan C, Halliday A, Chiva-Razavi S, Hollis KA, Balp MM. Impact of chronic idiopathic/ spontaneous urticaria on health related quality of life: aSSURE-CSU study results from Canada and the UK. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Grattan C, Balp MM, Halliday A, Abouzakouk M, Hollis KA, McBride DW, Westlund RE, Wolin DL, Tian H, Alexopoulos ST, Nakonechna A. ASSURE-CSU preliminary UK results: assessing the impact of CSU on absence from work and work productivity. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 Eastern Allergy Conference; May 28, 2015. Palm Beach, FL.

Sussman G, Lee J, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R, Tian H, Balp MM. ASSURE-CSU Canadian results: assessing the impact of chronic spontaneous/idiopathic urticaria on work productivity and indirect costs. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Sussman G, Waserman S, Keith P, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R. ASSURE-CSU Canadian results: assessing health utility in chronic spontaneous/idiopathic urticaria using the EQ-5D. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Copley-Merriman C, Zelt S, Clark M, Gnanasakthy A. Benefits of patient-reported outcomes in dermatology drug development. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Mahida SR, Seoane E, Klinger E, Salazar A, HER QL, Medoff J, Amato M, Dykes PC, Haas J, Bates D, Schiff G. Cost of reporting possible adverse drug reactions in medical outpatients using a telephonic interactive voice response system. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 20, 2015. Philadelphia, PA. [abstract] Value Health. 2015 May 1; 18(3):PA257. doi: 10.1016/j.jval.2015.03.1498

Mordin M, Brown TM, McLeod L, DeMuro C, Gnanasakthy A. Two companies following the FDA pro guidance leads to similar but different measures: a case study in psoriasis. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Campbell G, Alderson P, Smith AF, Warttig S. Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia. Cochrane Database Syst Rev. 2015 Apr 13;2015(4):CD009891. doi: 10.1002/14651858.CD009891.pub2

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Associations between comorbidities and hospitalizations among patients with chronic obstructive pulmonary disease (COPD). Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Association between nonadherence to chronic obstructive pulmonary disease (COPD) maintenance medications and medications for other chronic conditions. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Liu W, Schwab PE, Lane D. Analysis of oral anti-diabetes medication splitting patterns in Medicare Advantage Prescription Drug (MAPD) plans population. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Rosen J, Lane D, Schwab PE. Comparison of telephonic vs. face-to-face comprehensive medication reviews in COPD patients. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Raspa M, Sacco PN, Edwards AM, Bishop E, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 48th Annual Gatlinburg Conference; April 2015. New Orleans, LA.

Police RL, Trask PC, Wang J, Olivares R, Khan SB, Abbe A, Colosia AD, Njue AI, Sherrill EH, Ruiz-Soto R, Kaye JA, Hamadani M. Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):199-207. doi: 10.1016/j.clml.2014.09.008

Sussman G, Lynde CW, Chiva-Razavi S, Chambenoit O, Hollis K, Westlund RE, Balp MM. Canadian sub-analysis of the ASSURE-CSU study: demographic characteristics and health related quality of life in patients with chronic idiopathic urticaria. Poster presented at the American Academy of Dermatology Annual Meeting; March 21, 2015. San Francisco, CA.

Sussman G, Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis K, McBride D, Balp MM, Berard F, Gimenez-Arnau AM, Frutos JO, Canonica GW, Knulst AC, Grattan C. Assessment of economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: study design of the first observational study, ASSURE-CSU. Poster presented at the American Academy of Dermatology Annual Meeting; March 20, 2015.